Corpus Intelligence IC Memo — KANE COUNTY HOSPITAL 2026-04-26 08:27 UTC
IC Memo — KANE COUNTY HOSPITAL
Investment Committee Memorandum | UT | 25 beds | Grade C | EBITDA uplift $988K
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

KANE COUNTY HOSPITAL

CCN 461309 | KANE, UT | 25 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

KANE COUNTY HOSPITAL is a 25-bed safety-net/medicaid heavy in KANE, UT with $13.4M in net patient revenue and a -15.6% operating margin. The hospital serves a payer mix of 4.3% Medicare, 59.6% Medicaid, and 36.1% commercial.

Thesis: Turnaround. Our ML models identify $988K in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -15.6% to -8.2% (+738bps).

Net Revenue HCRIS$13.4M
Current EBITDA COMPUTED$-2.1M
Operating Margin COMPUTED-15.6%
Occupancy HCRIS61.5%
Revenue / Bed COMPUTED$536K
Net-to-Gross HCRIS89.2%
Distress Probability ML65.2%

2. Market Context & Competitive Position

59
UT Hospitals
8.0%
State Median Margin
28
Comparable Hospitals

UT has 59 Medicare-certified hospitals with a median operating margin of 8.0%. The target's margin of -15.6% places it below the state median. Among 28 size-comparable peers (12-50 beds), the median margin is 4.8%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (12-50), prioritizing same-state peers. 28 hospitals in the comp set.

HospitalStateBedsRevenueMargin
KANE COUNTY HOSPITAL (Target)UT25$13.4M-15.6%
CEDAR CITY HOSPITALUT48$136.8M31.4%
GUNNISON VALLEY HOSPITALUT25$130.4M-6.4%
LAYTON HOSPITALUT37$121.1M9.5%
PARK CITY HOSPITALUT37$120.8M13.7%
UINTAH BASIN MEDICAL CENTERUT33$119.9M1.8%
MOUNTAIN WEST MEDICAL CENTERUT36$96.1M38.5%
THE ORTHOPEDIC SPECIALTY HOSPIUT40$88.7M12.4%
CASTLEVIEW HOSPITALUT39$84.5M21.5%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $988K (738bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$281K+210bp18mo
Cost to Collect4.5%2.5%$268K+200bp12mo
Denial Rate Reduction12.0%6.5%$266K+199bp12mo
A/R Days Reduction5200.0%3800.0%$163K+122bp9mo
Clean Claim Rate88.0%96.0%$10K+7bp6mo

5. EBITDA Bridge

Net Collection Rate
$281K
Cost to Collect
$268K
Denial Rate Reduction
$266K
A/R Days Reduction
$163K
Clean Claim Rate
$10K
Total EBITDA Uplift$988K
Current EBITDA$-2.1M
+ RCM Uplift+$988K
Pro Forma EBITDA$-1.1M
Current Margin-15.6%
Pro Forma Margin-8.2%
WC Released (1x)$514K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-3.2M$-3.9M0.00x-100.0%
Base (11x exit)10.0x11.0x$-3.2M$-5.4M0.00x-100.0%
Bull Case9.0x11.0x$-2.9M$-3.1M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-2.9M$-4.3M0.00x-100.0%
Bear Case11.0x10.0x$-3.5M$-7.8M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-3.5M$-9.7M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
MediumElevated Medicaid exposure (59.6%)Medicaid reimburses below cost in most states. Mitigant: denial reduction lever has highest impact on Medicaid claims
HighElevated distress probabilityModel estimates 65.2% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 28 hospitals with 12-50 beds
  • Same-state prioritization (n=29)
  • Comp margins: P25=-6.8% / P50=4.8% / P75=12.7%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.